By SciTech Daily, 07/16/2022
“…A combination of androgen deprivation therapy—a common hormone injection—and pelvic lymph node radiotherapy prevented prostate cancer from therapy in nearly 90% of clinical trial participants for five years, according to a ground-breaking study from Cedars-Sinai Cancer…”
Read the entire article: https://scitechdaily.com/87-
